Actively Recruiting
Development and Preliminary Evaluation of a New Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Led by Lund University · Updated on 2026-02-20
48
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are developing and evaluating a new internet-delivered cognitive behavioral therapy (ICBT) program aimed at children and adolescents aged 8 to 17 years who have anxiety disorders. This study focuses on improving treatment for anxiety through a therapist-guided online program and assessing its preliminary effects on reducing anxiety severity. The study also explores participant experiences and factors that might influence treatment results, with the goal of refining the intervention for future use. The treatment involves a 12-week ICBT program accessed through a smartphone, tablet, or computer. The program is tailored into two versions based on age groups (8-12 and 13-17 years) and includes 12 modules for both the child or adolescent and their caregiver. Throughout the treatment, both the youth and caregiver communicate with a trained therapist via text, phone calls, and scheduled video or phone sessions to receive feedback and support. Participants will complete questionnaires at multiple points: at the start, during treatment, immediately after, and three months later. Some will also join focus group interviews to provide feedback on improving the program. The study measures anxiety levels using tools like the Pediatric Anxiety Rating Scale (PARS) and collects information on mood, well-being, therapy experiences, and any side effects. This comprehensive monitoring helps assess the program's impact and safety over the course of the study and follow-up.
CONDITIONS
Brief Title
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 8 to under 18 years
- Diagnosed with a principal DSM-5-TR anxiety disorder such as specific phobia, separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, panic disorder, or agoraphobia
- Able to read, write, and communicate in Swedish
- Has an available caregiver to support treatment
- Has access to a smartphone, tablet, or computer with internet
You will not qualify if you...
- Principal anxiety disorder related to blood-injection-injury phobia
- Established or suspected intellectual disability
- Mental disorder needing more immediate treatment than anxiety (e.g., psychotic disorders, bipolar disorder, anorexia nervosa, substance use disorders)
- Social, family, or educational difficulties needing more immediate management than anxiety
- Immediate risk to self or others requiring urgent attention, such as acute suicidality
- Received five or more CBT sessions for anxiety in the past 12 months
- Currently receiving psychological treatment for anxiety
- Started or changed psychotropic medication for anxiety within 8 weeks prior to assessment
- Participation in user involvement sessions in this study already
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online)
Duration - 12 weeks
Participants undergo a 12-week therapist-guided internet-delivered cognitive behavioral therapy program. They complete 12 modules and have individual contact with a trained therapist via text messages, telephone, or video calls, including a scheduled call approximately 4-5 weeks into treatment.
Continuous online interaction with therapist and scheduled communication including a call at week 4 or 5
Duration - Up to 3 months post-treatment
Participants are assessed post-treatment and again approximately 3 months after treatment ends to evaluate outcomes and maintain progress.
2 follow-up assessments (post-treatment and 3 months post-treatment)
Trial Site Locations
Total: 1 location
1
Barn- och ungdomshälsan, Länssjukhuset
Kalmar, Region Kalmar Län, Sweden, 391 85
Actively Recruiting
Research Team
P
Per Andrén, PhD
E
Eva Serlachius, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here